Nascent Biotech, Inc.
NBIO
$0.0007
-$0.0001-12.50%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -377.40K | -512.60K | -205.40K | -829.50K | -540.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -2.50K | 20.00K | 128.00K | 232.40K |
| Total Other Non-Cash Items | 56.00K | 125.50K | -87.80K | 409.40K | -87.20K |
| Change in Net Operating Assets | -3.40K | 37.80K | -56.90K | -49.40K | 232.30K |
| Cash from Operations | -324.70K | -351.70K | -330.10K | -341.50K | -162.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 0.00 | 225.00K | -- | -- |
| Total Debt Repaid | -- | 0.00 | -300.00K | -100.00K | -- |
| Issuance of Common Stock | -- | 100.00K | 25.00K | 1.44M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 100.00K | -50.00K | 1.34M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.70K | -251.70K | -380.10K | 994.50K | -162.70K |